Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christelle Liard

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Oncoimmunology|May 4, 2016
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune responseJessie Thalmensi, Elodie Pliquet, Christelle Liard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumorMagalie Dosset, Yann Godet, Charline Vauchy, et al.
Oncotarget|June 6, 2019
A DNA telomerase vaccine for canine cancer immunotherapyJessie Thalmensi, Elodie Pliquet, Christelle Liard, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Oncoimmunology|May 4, 2016
Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune responseJessie Thalmensi, Elodie Pliquet, Christelle Liard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Universal cancer peptide-based therapeutic vaccine breaks tolerance against telomerase and eradicates established tumorMagalie Dosset, Yann Godet, Charline Vauchy, et al.
Oncotarget|June 6, 2019
A DNA telomerase vaccine for canine cancer immunotherapyJessie Thalmensi, Elodie Pliquet, Christelle Liard, et al.
Pageof 2